Analysis of platelet glycoprotein (GP) expression by flow cytometry is applied for diagnostic confirmation of GP-associated thrombocytopathies. While platelet-rich plasma may be used for distinct identification of target events, this strategy is not feasible for small sample volumes or for patients showing low platelet counts and/or giant platelets. However, also the use of whole blood (WB) is hampered by the difficulty to discriminate platelets from red blood cells (RBC) in such patients. To circumvent these limitations, we evaluated the feasibility of a RBC gating-out strategy.
In addition to platelet GPIb, GPIIa/IIIa, as well as P-selectin (CD62P), citrated whole blood (CWB) samples were stained for RBC-specific glycophorin A (CD235a). CD235a-negative platelet events were further discriminated by forward-/side-scatter characteristics and platelet GP expressions analyzed relative to that of a healthy control sample processed in parallel.
Established reference intervals allowed for clear identification of decreased GPIIb/IIIa- or GPIb expression pattern in samples of patients with confirmed Glanzmann thrombasthenia or Bernard–Soulier syndrome, respectively. It could be shown that the analysis of 2,500 platelet events is sufficient for reliable GP expression analysis, rendering the proposed method applicable to samples with low platelet counts.
This study demonstrates the feasibility of CD235a-based exclusion of RBC for platelet GP expression analysis in CWB. In contrast to direct staining of platelet-specific antigens for target identification, this indirect gating out approach is generally applicable independent of any underlying platelet GP expression deficiency.
The authors thank Iris Neuerburg for expert technical assistance.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Competing interests: Authors state no conflict of interest.
Informed consent: Informed consent was obtained from all individuals included in this study.
Ethical approval: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013), and has been approved by the authors’ Institutional Review Board or equivalent committee.
1. Periayah, MH, Halim, AS, Mat Saad, AZ. Mechanism action of platelets and crucial blood coagulation pathways in hemostasis. Int J Hematol Oncol Stem Cell Res 2017;11:319–27.Search in Google Scholar
3. Nurden, AT, Pillois, X, Wilcox, DA. Glanzmann thrombasthenia: State of the art and future directions. Semin Thromb Hemost 2013;39:642–55. https://doi.org/10.1055/s-0033-1353393.Search in Google Scholar PubMed PubMed Central
4. Mumford, AD, Frelinger, AL3rd, Gachet, C, et al. A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders. Thromb Haemost 2015;114:14–25. https://doi.org/10.1160/th14-11-0999.Search in Google Scholar
6. Guillet, B, Bayart, S, Pillois, X, et al. A Glanzmann thrombasthenia family associated with a TUBB1-related macrothrombocytopenia. J Thromb Haemost 2019;17:2211–5. https://doi.org/10.1111/jth.14622.Search in Google Scholar PubMed
7. Hvas, AM, Favaloro, EJ. Platelet function analyzed by light transmission aggregometry. Methods Mol Biol. 2017;1646:321–331. https://doi.org/10.1007/978-1-4939-7196-1_25.Search in Google Scholar PubMed
8. Mutreja, D, Sharma, RK, Purohit, A, et al. Evaluation of platelet surface glycoproteins in patients with Glanzmann thrombasthenia: Association with bleeding symptoms. Indian J Med Res 2017;145:629–34. https://doi.org/10.4103/ijmr.IJMR_718_14.Search in Google Scholar PubMed PubMed Central
9. Linden, MD, Frelinger, AL3rd, Barnard, MR, et al. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004;30:501–11. https://doi.org/10.1055/s-2004-835671.Search in Google Scholar PubMed
10. Jennings, LK, Ashmun, RA, Wang, WC, Dockter, ME. Analysis of human platelet glycoproteins IIb-IIIa and Glanzmann’s thrombasthenia in whole blood by flow cytometry. Blood 1986;68:173–9. https://doi.org/10.1182/blood.v188.8.131.52.Search in Google Scholar
11. Andres, O, Henning, K, Strauß, G, et al. Diagnosis of platelet function disorders: A standardized, rational, and modular flow cytometric approach. Platelets 2018;29:347–56. https://doi.org/10.1080/09537104.2017.1386297.Search in Google Scholar PubMed
13. Lee, JA, Spidlen, J, Boyce, K, et al. MIFlowCyt: the minimum information about a Flow Cytometry Experiment. Cytometry A J Int Soc Anal Cytol. 2008;73:926–30. https://doi.org/10.1002/cyto.a.20623.Search in Google Scholar PubMed PubMed Central
14. Hermand, P, Gane, P, Huet, M, et al. Red cell ICAM-4 is a novel ligand for platelet-activated alpha IIbbeta 3 integrin. J Biol Chem 2003;278:4892–8. https://doi.org/10.1074/jbc.m211282200.Search in Google Scholar
15. Rosado, JA, Sage, SO. Protein kinase C activates non-capacitative calcium entry in human platelets. J Physiol 2000;529:159–69. https://doi.org/10.1111/j.1469-7793.2000.00159.x.Search in Google Scholar PubMed PubMed Central
16. Mussbacher, M, Schrottmaier, WC, Salzmann, M, et al. Optimized plasma preparation is essential to monitor platelet-stored molecules in humans. PLoS One 2017;12:e0188921. https://doi.org/10.1371/journal.pone.0188921.Search in Google Scholar PubMed PubMed Central
17. Rubak, P, Nissen, PH, Kristensen, SD, Hvas, AM. Investigation of platelet function and platelet disorders using flow cytometry. Platelets. 2016;27:66–74. https://doi.org/10.3109/09537104.2015.1032919.Search in Google Scholar PubMed
18. Ramström, S, Södergren, AL, Tynngård, N, Lindahl, TL. Platelet function determined by flow cytometry: New perspectives? Semin Thromb Hemost. 2016;42:268–81. https://doi.org/10.1055/s-0035-1570082.Search in Google Scholar PubMed
19. Pedersen, OH, Nissen, PH, Hvas, AM. Platelet function investigation by flow cytometry: Sample volume, needle size, and reference intervals. Platelets. 2018;29:199–202. https://doi.org/10.1080/09537104.2017.1353684.Search in Google Scholar PubMed
22. van Velzen, JF, Laros-van Gorkom, BA, Pop, GA, van Heerde, WL. Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers. Thromb Res 2012;130:92–8. https://doi.org/10.1080/09537109777249.Search in Google Scholar
23. Ginsberg, MH, Frelinger, AL, Lam, SC, et al. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies. Blood 1990;76:2017–23. https://doi.org/10.1182/blood.V76.10.2017.2017.Search in Google Scholar
24. Rubens, FD, Labow, RS, Waghray, G, Robblee, J. The importance of sampling site in the measurement of whole-blood platelet flow cytometry. J Cardiothorac Vasc Anesth 1998;12:309–13. https://doi.org/10.1016/S1053-0770(98)90012-X.Search in Google Scholar
25. Yardumian, DA, Mackie, IJ, Machin, SJ. Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 1986;39:701–12. https://doi.org/10.1136/jcp.39.7.701.Search in Google Scholar PubMed PubMed Central
26. Selle, F, James, C, Tuffigo, M, et al. Clinical and laboratory findings in patients with δ-storage pool disease: A case series. Semin Thromb Hemost 2017;43:48–58. https://doi.org/10.1055/s-0036-1584568ff.Search in Google Scholar
27. Knöfler, R, Eberl, W, Schulze, H, et al. Diagnosis of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e. V.). Hamostaseologie 2014;34:201–12. https://doi.org/10.5482/hamo-13-04-0024.Search in Google Scholar
28. Schmitz, G, Rothe, G, Ruf, A, et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998;79:885–96. https://doi.org/10.7892/boris.22178.Search in Google Scholar
29. Cai, H, Mullier, F, Frotscher, B, et al. Usefulness of flow cytometric mepacrine uptake/release combined with CD63 assay in diagnosis of patients with suspected platelet dense granule disorder. Semin Thromb Hemost 2016;42:282–91. https://doi.org/10.1055/s-0035-1564836.Search in Google Scholar PubMed
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2020-0014).
© 2020 Walter de Gruyter GmbH, Berlin/Boston